Alaunos Therapeutics
Price & Volume
Stats
See more52W Range | $1.60-$26 |
Market Cap | $2.6M |
Shares Short | 54,254 |
Financials
See moreRevenue (12 Mos) | $7,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$4.8M |
Diluted EPS | -$315.39 |
News
See moreYahoo Finance • last year
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
Yahoo Finance • last year
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
Yahoo Finance • 2 years ago
Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies
Yahoo Finance • 2 years ago
Alaunos Therapeutics Reports First Quarter 2023 Financial Results
About
CEO | Mr. Dale Curtis Hogue Jr. |
Address | 2617 Bissonnet Street, Houston, TX, United States, 77005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1 |
